The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today an advancement in the use of artificial intelligence (AI) to scale the generation of ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on ...

New research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in the journal ...

A “transformational” new study has uncovered the potential of GLP-1 jabs over and above their use for weight loss. Obesity is ...

As the use of GLP-1s soars in popularity, diners are wrestling with new restaurant etiquette dilemmas — and adjusting ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

About 600 college leaders recently signed a letter opposing the Trump administration's interference in higher education. The ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...